| Literature DB >> 21188143 |
Philippe M Hauser1, Frédéric X Burdet, Ousmane H Cissé, Laurent Keller, Patrick Taffé, Dominique Sanglard, Marco Pagni.
Abstract
Pneumocystis jirovecii is a fungus causing severe pneumonia in immuno-compromised patients. Progress in understanding its pathogenicity and epidemiology has been hampered by the lack of a long-term in vitro culture method. Obligate parasitism of this pathogen has been suggested on the basis of various features but remains controversial. We analysed the 7.0 Mb draft genome sequence of the closely related species Pneumocystis carinii infecting rats, which is a well established experimental model of the disease. We predicted 8'085 (redundant) peptides and 14.9% of them were mapped onto the KEGG biochemical pathways. The proteome of the closely related yeast Schizosaccharomyces pombe was used as a control for the annotation procedure (4'974 genes, 14.1% mapped). About two thirds of the mapped peptides of each organism (65.7% and 73.2%, respectively) corresponded to crucial enzymes for the basal metabolism and standard cellular processes. However, the proportion of P. carinii genes relative to those of S. pombe was significantly smaller for the "amino acid metabolism" category of pathways than for all other categories taken together (40 versus 114 against 278 versus 427, P<0.002). Importantly, we identified in P. carinii only 2 enzymes specifically dedicated to the synthesis of the 20 standard amino acids. By contrast all the 54 enzymes dedicated to this synthesis reported in the KEGG atlas for S. pombe were detected upon reannotation of S. pombe proteome (2 versus 54 against 278 versus 427, P<0.0001). This finding strongly suggests that species of the genus Pneumocystis are scavenging amino acids from their host's lung environment. Consequently, they would have no form able to live independently from another organism, and these parasites would be obligate in addition to being opportunistic. These findings have implications for the management of patients susceptible to P. jirovecii infection given that the only source of infection would be other humans.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21188143 PMCID: PMC3004796 DOI: 10.1371/journal.pone.0015152
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Number of KEGG orthologs (KO) predicted for P. carinii and S. pombe in 56 pathways that correspond to basal metabolism and cellular processesa.
| Number of KOs | ||||||
| Map no. |
|
|
|
| ||
| Carbohydrate Metabolism | ||||||
| Glycolysis/Gluconeogenesis | 10 | 23 | 22 | 14 | 0.64 | |
| Citrate cycle (TCA cycle) | 20 | 21 | 20 | 19 | 0.95 | |
| Pentose phosphate pathway | 30 | 15 | 15 | 8 | 0.53 | |
| Fructose and mannose metabolism | 51 | 11 | 10 | 8 | 0.80 | |
| Galactose metabolism | 52 | 10 | 7 | 4 | 0.57 | |
| Starch and sucrose metabolism | 500 | 15 | 11 | 12 | 1.09 | |
| Amino sugar and nucleotide sugar metabolism | 520 | 15 | 14 | 10 | 0.71 | |
| Inositol phosphate metabolism | 562 | 7 | 6 | 6 | 1.00 | |
| Pyruvate metabolism | 620 | 19 | 16 | 12 | 0.75 | |
| Glyoxylate and dicarboxylate metabolism | 630 | 7 | 4 | 3 | 0.75 | |
| Propanoate metabolism | 640 | 9 | 8 | 4 | 0.50 | |
| Butanoate metabolism | 650 | 9 | 8 | 4 | 0.50 | |
| OVERALL KOs | 101 | 86 | 62 | 0.72 | ||
| Energy Metabolism | ||||||
| Oxidative phosphorylation | 190 | 47 | 41 | 46 | 1.12 | |
| Carbon fixation in photosynthetic organisms | 710 | 11 | 11 | 9 | 0.82 | |
| Reductive carboxylate cycle (CO2 fixation) | 720 | 6 | 6 | 4 | 0.67 | |
| Nitrogen metabolism | 910 | 9 | 9 | 3 | 0.33 | |
| Sulfur metabolism | 920 | 11 | 8 | 2 | 0.25 | |
| OVERALL KOs | 82 | 73 | 63 | 0.86 | ||
| Lipid Metabolism | ||||||
| Fatty acid biosynthesis | 61 | 6 | 5 | 4 | 0.80 | |
| Steroid biosynthesis | 100 | 13 | 12 | 9 | 0.75 | |
| Glycerolipid metabolism | 561 | 6 | 3 | 3 | 1.00 | |
| Glycerophospholipid metabolism | 564 | 16 | 13 | 7 | 0.54 | |
| Ether lipid metabolism | 565 | 5 | 2 | 1 | 0.50 | |
| Sphingolipid metabolism | 600 | 7 | 5 | 2 | 0.40 | |
| Biosynthesis of unsaturated fatty acids | 1040 | 5 | 4 | 4 | 1.00 | |
| OVERALL KOs | 52 | 41 | 28 | 0.68 | ||
| Nucleotide Metabolism | ||||||
| Purine metabolism | 230 | 59 | 55 | 37 | 0.67 | |
| Pyrimidine metabolism | 240 | 47 | 44 | 32 | 0.73 | |
| OVERALL KOs | 77 | 72 | 48 | 0.67 | ||
| Amino Acid Metabolism | ||||||
| Alanine, aspartate and glutamate metabolism | 250 | 20 | 19 | 8 | 0.42 | |
| Glycine, serine and threonine metabolism | 260 | 21 | 20 | 7 | 0.35 | |
| Cysteine and methionine metabolism | 270 | 22 | 18 | 4 | 0.22 | |
| Valine, leucine and isoleucine degradation | 280 | 5 | 5 | 3 | 0.60 | |
| Valine, leucine and isoleucine biosynthesis | 290 | 13 | 14 | 5 | 0.36 | |
| Lysine biosynthesis | 300 | 10 | 7 | 0 | - | |
| Lysine degradation | 310 | 11 | 10 | 7 | 0.70 | |
| Arginine and proline metabolism | 330 | 26 | 24 | 3 | 0.13 | |
| Histidine metabolism | 340 | 8 | 9 | 0 | - | |
| Tyrosine metabolism | 350 | 8 | 7 | 2 | 0.29 | |
| Phenylalanine metabolism | 360 | 6 | 6 | 1 | 0.17 | |
| Tryptophan metabolism | 380 | 6 | 6 | 4 | 0.67 | |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 400 | 20 | 15 | 8 | 0.53 | |
| OVERALL KOs | 128 | 114 | 40 | 0.35 | ||
| Metabolism of Other Amino Acids | ||||||
| beta-Alanine metabolism | 410 | 5 | 5 | 0 | - | |
| Selenoamino acid metabolism | 450 | 10 | 8 | 4 | 0.50 | |
| Cyanoamino acid metabolism | 460 | 6 | 5 | 0 | - | |
| Glutathione metabolism | 480 | 13 | 13 | 7 | 0.54 | |
| OVERALL KOs | 31 | 28 | 11 | 0.39 | ||
| Glycan Biosynthesis and Metabolism | ||||||
| N-Glycan biosynthesis | 510 | 18 | 16 | 11 | 0.69 | |
| Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 563 | 8 | 8 | 5 | 0.63 | |
| OVERALL KOs | 26 | 24 | 16 | 0.67 | ||
| Metabolism of Cofactors and Vitamins | ||||||
| Ubiquinone and other terpenoid-quinone biosynthesis | 130 | 5 | 3 | 3 | 1.00 | |
| One carbon pool by folate | 670 | 12 | 9 | 5 | 0.56 | |
| Riboflavin metabolism | 740 | 8 | 6 | 4 | 0.67 | |
| Vitamin B6 metabolism | 750 | 7 | 7 | 4 | 0.57 | |
| Nicotinate and nicotinamide metabolism | 760 | 6 | 5 | 3 | 0.60 | |
| Pantothenate and CoA biosynthesis | 770 | 9 | 9 | 1 | 0.11 | |
| Folate biosynthesis | 790 | 7 | 3 | 2 | 0.67 | |
| Porphyrin and chlorophyll metabolism | 860 | 14 | 13 | 11 | 0.85 | |
| OVERALL KOs | 67 | 54 | 32 | 0.59 | ||
| Transcription | ||||||
| RNA polymerase | 3020 | 17 | 17 | 12 | 0.71 | |
| Spliceosome | 3040 | 12 | 12 | 11 | 0.92 | |
| OVERALL KOs | 29 | 29 | 23 | 0.79 | ||
| Translation | ||||||
| Aminoacyl-tRNA biosynthesis | 970 | 24 | 24 | 21 | 0.88 | |
| GENERAL OVERALL KOs | 485 | 427 | 278 | 0.65 | ||
The reference gene numbers of S. pombe are those obtained from KEGG. Maps with less than five reference genes of S. pombe are not shown. KOs which are redundant in the pathways are counted only once in “OVERALL KOs”.
Number of enzymes dedicated to the biosyntheses of amino acids identified in P. carinii and S. pombe a.
| No of dedicated enzymes | |||
| Amino acid | in | in | in |
| Ala | 1 | 1 | 0 |
| Asp | 1 | 1 | 1 |
| Asn | 1 | 1 | 0 |
| Arg | 3 | 3 | 0 |
| Cys | 2 | 2 | 0 |
| Glu | 1 | 1 | 1 |
| Gln | 1 | 1 | 0 |
| Gly | 1 | 1 | 0 |
| His | 6 | 6 | 0 |
| Ile | 4 | 4 | 0 |
| Leu | 3 | 3 | 0 |
| Lys from aspartate | 0 | 0 | 0 |
| Lys from pyruvate | 7 | 7 | 0 |
| Met | 3 | 3 | 0 |
| Phe | 2 | 2 | 0 |
| Pro | 1 | 1 | 0 |
| Ser | 3 | 3 | 0 |
| Thr from glycine | 1 | 1 | 0 |
| Thr from homoserine | 2 | 2 | 0 |
| Trp | 5 | 5 | 0 |
| Tyr | 2 | 2 | 0 |
| Val | 4 | 4 | 0 |
| TOTAL | 54 | 54 | 2 |
The reference gene numbers of S. pombe are those obtained from KEGG.
The four enzymes are the same for Ile and Val syntheses.
One of the enzymes is also involved in Ile and Val syntheses.
Some features of free-living microorganisms and obligate parasites.
| Genome size (approx. Mb) | Gene content (approx. no.) | Number of rDNA loci (approx. no.) | Minimum metabolic requirements | Number of hosts | |
|
| 13 | 6300 | 150 | none | 0 |
|
| 14 | 5000 | 120 | none | 0 |
|
| 23 | 5300 | 4–8 | amino acids | 2 |
|
| 33 | 6200 | 20–60 | amino acids | 2 |
|
| 10 | 4000 | 4–5 | amino acids | 1 |
|
| 8 | 4000 | 1 | amino acids cholesterol | 1 |
|
| 3 | 2000 | 20 | amino acids nucleotides lipids vitamins | 1 |
Proteomes investigated for transfer the KEGG annotations of the P. carinii predicted proteome.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Figure 1Principle of the numerical experience used to optimize the precision and recall of the annotation predictions.
The S. pombe proteome (right box) was blasted against an intermediary set of fungal proteins, i.e. the proteome of S. cerevisiae in this example (middle box), and only the highest scoring blast matches were retained. By utilizing the S. cerevisiae mapping to the KEGG Orthologs (between the middle and left boxes), one can produce a mapping through S. cerevisiae of the S. pombe proteins to the KEGG Orthologs. The latter mapping can then be compared with the one that is actually provided by KEGG to compute precision and recall values. The experience was systematically repeated using different proteomes as intermediary data sets (or several proteomes at once), to eventually determine the optimal one.
Figure 2Estimation of the quality of the mapping onto KEGG maps by performing a re-prediction of the annotation of S. pombe proteome through intermediary data set consisting of one, two, three, or 18 fungal proteomes.
The KO - S. pombe association pairs obtained by “blasting” an intermediary data set were evaluated a posteriori as true positive (TP) or false positive (FP) according to the KO - S. pombe mapping which is provided by KEGG. Those missed KO - S. pombe pairs existing in KEGG were taken as false negatives (FN). The overall quality of the obtained mapping can be expressed in terms of precision TP/(TP+FP) and recall TP/(TP+FN).